Literature DB >> 18954299

Early diagnosis and successful treatment of acute antibody-mediated rejection of a renal transplant.

Ya-Wen Yang1, Wei-Chou Lin, Ming-Shiou Wu, Po-Huan Lee, Meng-Kun Tsai.   

Abstract

Antibody-mediated rejection is a delicate situation. It rarely occurs but when it does, it usually results in graft dysfunction and frequently, graft loss. There has been no standard protocol for treating antibody-mediated rejection, although several therapeutic protocols have been recommended. Early detection and treatments of suspected antibody-mediated rejection can secure the graft and improve its function. Here, we describe a typical case of antibody-mediated rejection in a 46-year-old woman who was successfully treated with intravenous immunoglobulin, plasmapheresis, and the anti-CD20 monoclonal antibody, rituximab.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18954299

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN： 1304-0855            Impact factor:   0.945


  5 in total

1.  Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS.

Authors:  Weiguo Sui; Liling Huang; Yong Dai; Jiejing Chen; Qiang Yan; He Huang
Journal:  Clin Exp Med       Date:  2010-04-08       Impact factor: 3.984

Review 2.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

3.  A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy.

Authors:  Hongjie Wang; Ying Liu; Zong-Yi Li; Xiaolong Fan; Akseli Hemminki; André Lieber
Journal:  Blood       Date:  2009-11-12       Impact factor: 22.113

4.  Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients.

Authors:  F Ahmadi; S Dashti-Khavidaki; M R Khatami; M Gatmiri; F Ahmadi; M Mahdavi-Mazdeh; M T Najafi; Z Foroozanfar; A Mahdizadeh; S Derafshi
Journal:  Int J Organ Transplant Med       Date:  2019

Review 5.  Advances in diagnosing and managing antibody-mediated rejection.

Authors:  Stanley C Jordan; Nancy Reinsmoen; Alice Peng; Chih-Hung Lai; Kai Cao; Rafael Villicana; Mieko Toyoda; Joseph Kahwaji; Ashley A Vo
Journal:  Pediatr Nephrol       Date:  2010-01-14       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.